
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Integrated Nanotherapeutics Inc (INT) is a preclinical company developing antigen specific immune tolerance therapies using mRNA-Lipid nanoParticles (LNP). We have demonstrated that our mRNA-LNP therapy can reverse Type 1 Diabetes (T1D) in NOD mice. We were recently awarded a grant from Breakthrough T1D (formerly JDRF). With a growing pipeline in other T-cell-driven autoimmune diseases, we have successfully demonstrated in additional animal models that our tolerizing-LNP induces antigen-specific immune tolerance. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision...
Nanotechnology,immunology,drug delivery systems,diabetes,nanoparticles,formulation process,r&d,immune tolerance,autoimmune diseases,and lipid nanoparticles
Integrated nanotherapeutics inc operates in the Biotechnology industry.
Integrated nanotherapeutics inc's revenue is 11m - 100m
Integrated nanotherapeutics inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.